News Highlights

APEC USAID GHSA Policy Forum On Infection Control

 

image

 

The Philippine Hospital Association sizzled in Seoul Korea.

The recently concluded Policy Forum by APEC USAID GHSA on Infection Control Infrastructure held on Sept. 7-8, 2015 at the Grand Intercontinental  Seoul Parnas was attended by senior officials of government and private organizations from the various parts of the Asia Pacific Region.

The PHA was well represented by :

  1. PHA President, Dr. Ruben C. Flores,-with his two presentations
    1. Day One - “The Healthcare Associated Infection Situation in the Philippines"
    2. Day Two - “Hospital Associations’ Initiatives in Infection Prevention And Control
  2. PHA Chairman of the advocacy on Best Hospital Practices on Infection Prevention and Control Awards Dr. Huberto Lapuz  - listened, took notes and networked with the other delegates. Contributed his thoughts during the break out sessions.
  3. PHA Executive Director and Coordinator of the PHA advocacy on Best Practices on IPC-among other things:
    1. coordination with event hosts on the multitude of requirements for the PHA’s attendance to the forum;
    2. coordination with Dr. Ruben Flores and the event host on his presentation materials, schedules, checking of venues and other activities of the PHA delegation
    3. networking with APEC delegates and speakers , took notes and secured materials and copies of presentations by speakers
    4. participated in the break out sessions’
    5. handed out tokens to elect delegates and APEC organizers and Secretariat with the compliments of the PHA;


To name a few, other personalities in the event were as follows:

  1. Ms. Paula Wilson, President and CEO, Joint Commission Resources / Joint Commission International
  2. K.K. Kalra, Chief Executive Officer, National Accreditation Board for Hospitals and Healthcare Providers, Quality Council of India
  3. Prof. Chris Baggoley, Chief Medical Officer, Department of Health, Australia
  4. Dr. Jun-Yong Choi, Head Commissioner of Korean Nosocomial Infections Surveillance System, Associate Professor of Internal Medicine, Division of Infectious Diseases, Yonsei Severance Hospital, Republic of Korea
  5. Dr. Shu-Hui Tseng, Division Director, Division of  Infection Control and Biosafety, Centers for Disease Control, Chinese Taipei
  6. Dr. Ling Moi Lin, President, Asia Pacific, Society of Infection Control and Senior Consultant , Director of Infection Control, Singapore
  7. Dr. Jin-Hong Yoo, President, Korean Society for Healthcare-associated Infection Control and Prevention (KOSHIC)
  8. DR. Hu Bijie, Director at Dept. of Infectious Diseases, Zhongshan Hospital, Sudan University , China
  9. Dr. Gorgi Ivanov, CEO, Federal Sate Institution Consultative and Diagnostic Center, Presidential Administration of the Russian Federation
  10. Dr. Luis Cuellar, Head, Infection Control Committee, National Cancer Institute, Peru
  11. Dr. Benedict Sim Lim Heng, Consultant Physician and Infectious Disease Consultant in Department of Medicine, Hospital Sungai Buloh, Malaysia
  12. Dr. Nalini Singh, Professor of Paediatrics, Geroge Washington University Schools of Medicine and Public Health, Children’s National Medical Centre, United States.
  13. Dr. Carol Rao, Epidemiology Section Chief, Centre for disease Control and PRevention, United States
  14. Dr. Yi-Chun Lo, Chief Medical Officer, Director of Office of Preventive Medicine, Centers for Disease Control, Chinese Taipei
  15. Dr. Keigo Shibayama, Director dEpartment of Bacteriology, National Institute of Infectious Diseases and Chairman, Japan Nosocomial Infections Surveillance, Japan
  16. Dr. Jun-Yong Choi, Head Commissioner of Korean Nosocomial Infections Surveillance System, Associate Prof of Internal Med, Division of Infectious Diseases, Yonsei Severance HOspital, Republic of Korea.


Most noteworthy were the roles of :

  1. Dr. Maureen Goodenow, Senior Advisor for Health, Science, Technology, and Innovation, Office of Economic Policy, Bureau of East Asian and Pacific Affairs, Department of State, United States
  2. Ambassador Jimmy Kolker, Assistant Secretary for Global Affairs, Department of Health and Human Services, United States
  3. Dr. Hur, Young Joo, Director General, Center for Infectious Disease Control, Korea Centers for Disease Control and Prevention, Ministry of Health and Welfare, Republic of Korea;
  4. Nadira Mailewa, US-APEC Technixal Assistance to Advance Regional Integration (US ATAARI) initiative.
  5. Michael Schmitz, APEC Life Sciences Innovation Forum
  6. Ambassador Bonnie Jenkins, Coordinator for Threat Reduction Prgorams, United States
  7. Ryan McFarlane, Planning Group Chair, APEC Life Sciences Innovation Forum



While volumes of information were obtained  and can be made available for reference by the PHA Board and the general membership, they can be summarised briefly as follows:

  1. In general the public policy frameworks to advance and measure progress in IPC was given focus which included among other things presentations on:
    1. The role of governments in advancing and measuring progress in infection prevention and control.  Panelists will also discuss examples of how APEC governments are using public policy tools and frameworks, such as tiered-accreditation programs and outcome-based payment schemes, to promote and measure improvements in infection control.
    2. The role of accreditation in driving improvements in IPC.
    3. How accreditation and quality care standards are driving improvements in IPC in India.
    4. Discuss how hospital associations are working with governments in the Philippines and throughout the Asia-Pacific region to improve IPC.
    5. How Australia is promoting compliance with IPC policies. Discuss the incentives for compliance and the penalties for non-compliance.  What lessons learned can be shared with other APEC Economies?
    6. How Korea is advancing and measuring progress in IPC, with focus on the Korean Nosocomial Infections Surveillance System.
    7. How Chinese Taipei is advancing and measuring progress in IPC, with a focus the Chinese Taipei Nosocomial Infections Surveillance System, development of surveillance system and sharing of available data.


The PHA take away on its participation are the awareness that :

  1. IPC is a serious global concern
  2. That even the other developed countries leaves much to be desired in their system of handling IPC
  3. PHA’s advocacy on IPC is in the right directions and learnings from the efforts of the others can and should be adopted.